Cargando…
Urolithin A improves mitochondrial health, reduces cartilage degeneration, and alleviates pain in osteoarthritis
Osteoarthritis (OA) is the most common age‐related joint disorder with no effective therapy. According to the World Health Organization, OA affects over 500 million people and is characterized by degradation of cartilage and other joint tissues, severe pain, and impaired mobility. Mitochondrial dysf...
Autores principales: | D'Amico, Davide, Olmer, Merissa, Fouassier, Andréane M., Valdés, Pamela, Andreux, Pénélope A., Rinsch, Chris, Lotz, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381911/ https://www.ncbi.nlm.nih.gov/pubmed/35778837 http://dx.doi.org/10.1111/acel.13662 |
Ejemplares similares
-
Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults
por: Singh, Anurag, et al.
Publicado: (2022) -
Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults to achieve consistent levels across the population
por: Singh, Anurag, et al.
Publicado: (2021) -
RNA-binding proteins that are highly expressed and enriched in healthy cartilage but suppressed in osteoarthritis
por: Swahn, Hannah, et al.
Publicado: (2023) -
Potential of Urolithin A to improve joint health
por: D’Amico, Davide, et al.
Publicado: (2023) -
Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial
por: Liu, Sophia, et al.
Publicado: (2022)